Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finn

Showing results (81-90 of 407) with videos related to

Pageof 41
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
T cell receptor beta-chain selection in human allograft rejectionM C Miceli, O J Finn
Medicine and Health, Rhode Island|December 21, 2005
Bio-emergency preparedness in Rhode Island: a role for urgent care centers?Matthew J Finn, Marguerite A Neill
Nature Biotechnology|April 7, 1998
Mimic 1 of MUC1O J Finn, S J Gendler
Progress in Clinical and Biological Research|January 1, 1989
Role of novel adjuvants in specific active immunotherapyJ L Cantrell, D J Finn
Cancer Treatment and Research|October 11, 2005
Tumor antigens and tumor antigen discoveryDaniel F Graziano, Olivera J Finn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
A decade in the life of tumor immunologyO J Finn, M T Lotze
Annals of the New York Academy of Sciences|May 9, 2013
Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomasPamela L Beatty, Olivera J Finn
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 29, 1998
Third Keystone Symposium on Cellular Immunology and the Immunotherapy of Cancer. IntroductionO J Finn, M T Lotze
Methods in Enzymology|February 1, 2020
Flow cytometry-based assessment of direct-targeting anti-cancer antibody immune effector functionsMichelle L Miller, Olivera J Finn
Seminars in Immunology|June 24, 2010
Cancer vaccines: The state of the artOlivera Olja J Finn, Jacques Banchereau
Pageof 41

Showing results (81-90 of 407) with videos related to

Sort By:
Pageof 41
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
T cell receptor beta-chain selection in human allograft rejectionM C Miceli, O J Finn
Medicine and Health, Rhode Island|December 21, 2005
Bio-emergency preparedness in Rhode Island: a role for urgent care centers?Matthew J Finn, Marguerite A Neill
Nature Biotechnology|April 7, 1998
Mimic 1 of MUC1O J Finn, S J Gendler
Progress in Clinical and Biological Research|January 1, 1989
Role of novel adjuvants in specific active immunotherapyJ L Cantrell, D J Finn
Cancer Treatment and Research|October 11, 2005
Tumor antigens and tumor antigen discoveryDaniel F Graziano, Olivera J Finn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
A decade in the life of tumor immunologyO J Finn, M T Lotze
Annals of the New York Academy of Sciences|May 9, 2013
Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomasPamela L Beatty, Olivera J Finn
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 29, 1998
Third Keystone Symposium on Cellular Immunology and the Immunotherapy of Cancer. IntroductionO J Finn, M T Lotze
Methods in Enzymology|February 1, 2020
Flow cytometry-based assessment of direct-targeting anti-cancer antibody immune effector functionsMichelle L Miller, Olivera J Finn
Seminars in Immunology|June 24, 2010
Cancer vaccines: The state of the artOlivera Olja J Finn, Jacques Banchereau
Pageof 41